España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
CytoMed Therapeutics
GDTC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
CytoMed Therapeutics (GDTC) Forecast
News
Earnings
CytoMed Therapeutics (GDTC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for CytoMed Therapeutics (NASDAQ:GDTC) Stock
CytoMed Therapeutics Stock (NASDAQ: GDTC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, October 10, 2024
Benchmark Reiterates Speculative Buy on CytoM...
Benzinga Newsdesk
Thursday, October 03, 2024
CytoMed Therapeutics Has Acquired The License...
Benzinga Newsdesk
Wednesday, July 17, 2024
CytoMed Therapeutics shares are trading highe...
Benzinga Newsdesk
Cytomed Therapeutics, Through Its Wholly Owne...
Benzinga Newsdesk
Tuesday, June 11, 2024
Benchmark Reiterates Speculative Buy on CytoM...
Benzinga Newsdesk
Wednesday, March 20, 2024
CytoMed Therapeutics Diversifies Into Regener...
Benzinga Newsdesk
Monday, March 18, 2024
CytoMed Therapeutics Has Obtained Board Appro...
Benzinga Newsdesk
Monday, March 04, 2024
CytoMed Therapeutics Announces Research Colla...
Benzinga Newsdesk
Wednesday, February 14, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, February 07, 2024
Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
US Stocks Gain; Uber Posts Upbeat Sales
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Monday, January 29, 2024
Cytomed Therapeutics Announced That The Intel...
Benzinga Newsdesk
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Wednesday, December 27, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, December 05, 2023
CytoMed Therapeutics Signs HOA and MOU to Adv...
Benzinga Newsdesk
Monday, December 04, 2023
Benchmark Reiterates Speculative Buy on CytoM...
Benzinga Newsdesk
Friday, November 17, 2023
CytoMed Therapeutics Reports 1H 2023 Financia...
Benzinga Newsdesk
Monday, October 09, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Monday, September 25, 2023
CytoMed Therapeutics Announced That Its Exclu...
Benzinga Newsdesk
Tuesday, August 29, 2023
CytoMed Expands Research Collaboration Into China After Entering Into MOU With China-Based Hangzhou CNK Therapeutics Co., Ltd.
Happy Mohamed
Tuesday, August 15, 2023
CytoMed Therapeutics Announces China Research Collaboration To Enhance Its Allogeneic CAR γδ T In Vivo Persistency; The MOU Signed By Cytomed And Hangzhou CNK Therapeutics Co., Ltd Is The First Of Several Collaborative Efforts In North Asia
Happy Mohamed
Friday, July 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Benzinga Insights
Benchmark Initiates Coverage On CytoMed Thera...
Benzinga Newsdesk
Thursday, July 13, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, July 12, 2023
CytoMed Therapeutics Limited shares are tradi...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, July 11, 2023
Shares of low-float CytoMed Therapeutics are ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Dow Jumps Over 100 Points; US Small Business Optimism Index Tops Estimates
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Friday, July 07, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, July 06, 2023
A*STAR Spinoff CytoMed Therapeutics Announce ...
Benzinga Newsdesk
Friday, May 12, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, May 10, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, May 09, 2023
CytoMed Therapeutics Shares Resume Trading Fo...
Happy Mohamed
CytoMed Therapeutics Shares Halted On Circuit...
Happy Mohamed
CytoMed Therapeutics Shares Resume Trade Foll...
Happy Mohamed
CytoMed Therapeutics Shares Halted On Circuit...
Happy Mohamed
CytoMed Therapeutics Limited Announces Collaboration With MD Anderson Cancer Center To Advance Allogeneic Off-The-Shelf Gamma Delta T Cells In Oncology
Happy Mohamed
Friday, April 21, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Friday, April 14, 2023
CytoMed Therapeutics Shares Open For Trade At...
Steve Krause
CytoMed Therapeutics Indicating $4 On 245K Sh...
Steve Krause
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch